Athira Pharma Faces Delisting Concerns
Ticker: LONA · Form: 8-K · Filed: Apr 16, 2025 · CIK: 1620463
| Field | Detail |
|---|---|
| Company | Athira Pharma, INC. (LONA) |
| Form Type | 8-K |
| Filed Date | Apr 16, 2025 |
| Risk Level | high |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-standards, regulatory
TL;DR
Athira Pharma might be delisted - big trouble ahead.
AI Summary
Athira Pharma, Inc. has filed an 8-K report on April 15, 2025, indicating a notice of delisting or failure to satisfy a continued listing rule or standard. The company, formerly known as M3 Biotechnology, Inc., is based in Bothell, WA.
Why It Matters
This filing signals potential issues with Athira Pharma's continued listing on an exchange, which could impact its stock trading and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards is a severe event that can lead to significant stock price declines and operational challenges.
Key Players & Entities
- Athira Pharma, Inc. (company) — Registrant
- M3 Biotechnology, Inc. (company) — Former company name
- April 15, 2025 (date) — Date of earliest event reported
- Bothell, WA (location) — Principal executive offices
FAQ
What specific listing rule or standard has Athira Pharma failed to satisfy?
The filing does not specify the exact rule or standard that Athira Pharma has failed to satisfy, only that a notice has been issued.
What is the potential impact of this notice on Athira Pharma's stock trading?
A notice of delisting or failure to meet listing standards can lead to increased volatility, potential trading halts, and a significant decline in stock price.
Has Athira Pharma provided any details on steps it plans to take to rectify the situation?
This specific 8-K filing does not contain information regarding Athira Pharma's plans to address the delisting concerns.
When was Athira Pharma, Inc. formerly known as?
Athira Pharma, Inc. was formerly known as M3 Biotechnology, Inc., with a date of name change on September 24, 2014.
What is the primary business of Athira Pharma, Inc. according to its SIC code?
According to its Standard Industrial Classification (SIC) code [2836], Athira Pharma, Inc. is involved in Biological Products (No Diagnostic Substances).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 16, 2025 regarding Athira Pharma, Inc. (LONA).